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Authors’ reply to letters from
Egilman et al and Oliver et al
Dr Egilman and colleagues claim our
report1 implies that chrysotile does not
cause mesothelioma. So did the
International Chrysotile Association, the
website of which highlighted our paper
with the misleading headline ‘reliable scien-
tiﬁc data conﬁrms negligible role of chryso-
tile in UK patients with asbestos-related lung
disease’.2 Our results are consistent with the
strong evidence that chrysotile did not cause
a large proportion of UK mesotheliomas,
but they certainly do not show that the risk
is negligible. We said ‘the rapid clearance of
chrysotile from the lung with a half-life of a
few months explains its virtual absence in
our samples, and implies that we cannot
estimate its effects except by noting that
amphibole lung burdens account very well
for mesothelioma incidence’. In relation to
lung cancer, we said, ‘the contribution of
chrysotile to current UK lung cancer rates is
not known and may be impossible to ascer-
tain’. Uncontrolled chrysotile use caused
large lung cancer and asbestosis risks, and
its abandonment by Europe and many other
countries stimulated development of novel
alternatives rather than causing economic
damage. These are sufﬁcient grounds for
worldwide replacement of chrysotile with
safer substitutes. The mesothelioma risk,
although less, reinforces the case.
Dr Egilman and colleagues also criticise
our analysis of lung rather than pleural
tissue and our restriction of transmission
electron microscope (TEM) counting to
asbestos ﬁbres longer than 5 μm. We
observed that ‘for ﬁbres of speciﬁed
dimension it seems reasonable to assume a
linear relationship between inhaled dose,
ﬁbre concentration in pleural stomata and
our measurements in lung parenchyma’.
After reviewing the human, animal and in
vitro evidence, an expert panel convened
by the US Agency for Toxic Substances
and Disease Registry concluded that ‘There
is a strong weight of evidence that asbestos
and synthetic vitreous ﬁbers shorter than
5 μm are unlikely to cause cancer in
humans’.3 Our protocol for anonymised
sample preparation used minimal ultra-
sonic treatment and did not involve freeze-
drying, and we used a single laboratory.
They cite the assumption in 1978 that
mesotheliomas in the Rochdale factory
were caused by chrysotile.4 This predated
the admission by the company that over
10 000 tonnes of crocidolite were also pro-
cessed between 1932 and 1968.5
Dr Oliver and colleagues missed several
details. There were no next-of-kin or
proxy interviews, our statistical deﬁnition
of asbestos-related lung cancer did not
involve asbestosis (which would be biased)
and we showed that our estimated ratio of
mesothelioma to asbestos-related lung
cancer is consistent with two population-
based UK studies. That ‘the gold standard
for asbestos-exposure assessment is the
occupational history, not ﬁber burden’ is
contradicted by the dose–response we
observed within occupational groups and
is particularly unhelpful in relation to
Britain’s high mesothelioma rate in both
sexes due to environmental asbestos
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exposure from unidentiﬁed sources.6 The
strong correlation we observed between
lung burden and mesothelioma risk will
not ‘imperil the diagnosis of asbestos-
related disease, victim compensation, and
public health measures aimed at primary
and secondary prevention’. Our results,
together with lung burdens in younger
people, will enable the risks associated
with current exposures from asbestos in
buildings to be estimated, informing
effective disease prevention.
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